[
  {
    "criterion": "Recognizes that the question posed uses medical jargon with correct technicality understood from a healthcare context, likely communicated by a gastroenterologist within a health profession context.",
    "points": 9,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Provides guidelines on rifaximin prophylaxis in hepatic encephalopathy as an add-on to lactulose only for secondary prophylaxis and not routinely recommended for primary prophylaxis.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "References the indications based on the current guidelines by the American Academy of the Study of Liver Diseases after a patient has had at least two episodes of HE within six months.",
    "points": 5,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Clarifies that the decision to add Rifaximin is not only based on the West Haven stage, but that the recurrence pattern is a stronger determinant for initiation.",
    "points": 3,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Fails to recommend individualization of patient care based on risk factors, response to lactulose, and overall clinical context.",
    "points": -5,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Does not offer a clinical approach where lactulose is first optimized to resolve recurrences or the current episode.",
    "points": -7,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Fails to mention that in some cases clinicians may start Rifaximin in high-risk features, such as advanced liver disease, poor response to lactulose, and frequent hospitalizations, but the recommendation is based on clinical judgment.",
    "points": -9,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Interprets \"What does this mean?\" as the user being a non-physician asking about a question a physician is asking about patient management.",
    "points": 9,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Summarizes that a gastroenterologist is asking about the role of rifaximin in hepatic encephalopathy treatment.",
    "points": 8,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Advises on the role of rifaximin as an add-on to lactulose.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Advises that rifaximin can be used as an adjunct to lactulose for secondary prophylaxis following one or more episodes of hepatic encephalopathy.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Advises that the addition of rifaximin is not mainly based on the severity or stage of encephalopathy.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Fails to recognize that the question is framed as a non-physician user and provides a detailed description of hepatic encephalopathy management from the perspective of a physician.",
    "points": -8,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  }
]